Jazz Pharmaceuticals
JAZZ
#2088
Rank
โ‚ฌ7.31 B
Marketcap
120,99ย โ‚ฌ
Share price
1.25%
Change (1 day)
8.26%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): โ‚ฌ0.27 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ3.90 Billion. In 2023 the company made an earning of โ‚ฌ0.28 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.27 B-2.72%
2023 โ‚ฌ0.28 B-179.92%
2022 -โ‚ฌ0.36 Billion230.37%
2021 -โ‚ฌ0.11 Billion-141.02%
2020 โ‚ฌ0.26 B-39.45%
2019 โ‚ฌ0.43 B-14.2%
2018 โ‚ฌ0.50 B20.03%
2017 โ‚ฌ0.42 B-17.15%
2016 โ‚ฌ0.50 B22.14%
2015 โ‚ฌ0.41 B187.64%
2014 โ‚ฌ0.14 B-50.79%
2013 โ‚ฌ0.29 B73.63%
2012 โ‚ฌ0.16 B41.69%
2011 โ‚ฌ0.11 B116.61%
2010 โ‚ฌ55.19 M262.77%
2009 โ‚ฌ15.21 M-111.33%
2008 -โ‚ฌ0.14 Billion1.31%
2007 -โ‚ฌ0.14 Billion77.8%
2006 -โ‚ฌ74.56 Million36.59%
2005 -โ‚ฌ54.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ2.29 Billion-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ2.00 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.16 B 4,181.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.78 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel